Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Aug. 27, 2026 |
Jun. 30, 2026 |
|
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | On May 3, 2024, the Company was made aware that its long-standing auditors, BF Borgers CPA PC, had been denied the privilege of appearing or practicing before the Securities and Exchange Commission (the “SEC”) as an accountant. In view of the nature of the actions taken by the SEC in relation to the Company’s former auditor, the SEC required the Company to reaudit 2 years of its financial statements resulting in a deficiency in the Company’s filings entirely due to circumstances beyond the control of the Company. The Company appointed a new registered public accounting firm: Fruci & Associates II PLLC, Certified Public Accountants based in Spokane, Washington (“Fruci & Associates”) to replace BF Borgers. This present 2024 Annual Report filed on Form 10-K/A (the “Report”) includes modifications resulting from the completion of the audit carried out by Fruci & Associates and is duly filed as amended Form 10-K/A of the April 30 2025, filing of the unaudited 2024 10K. In this respect, attention is drawn to the Report of Independent Registered Public Accounting Firm at the beginning of Item 8. The principal changes to the 10-K/A are as follows: The Report includes a Cybersecurity Disclosure as Item 1C. Two important adjustments were made to the Company’s financial statements: 1) the Company’s technology, considered in filings since September 2021 to be an indefinite intangible asset was reevaluated and is now considered to have an estimated useful life equivalent to the period of its patent protection, appropriate amortization being charged to the value of the asset accordingly. This has resulted in an adjustment of $458k to the asset value as of December 31, 2023. This was recorded as a charge of $149,782 against the value of the asset as amortization for year ended 2023 and $149,782 against the value of the asset as amortized for year ended 2024. The accumulated amortization from 2021 to year ended 2024 is $957,942 total. The Company also wrote off a total of principal and interest totaling $523,102 for an uncollectable account receivable from a series of loans to UltiMetX. In Item 7, Management Discussion and Analysis of Financial Condition and Results of Operations was modified to reflect other changes made to the Report. Matters relating to projected timing in the Report have been changed from the original disclosure better to reflect the current belief of management regarding such projections. Where necessary or helpful, the circumstances relating to the need for such adjustment are also reported. A few other changes were made to punctuation and grammar that do not affect the sense of disclosure, and where dollar figures included cents, these were rounded up to the nearest dollar. FORWARD LOOKING STATEMENTS Forward-Looking Statements This Annual Report on Form 10-K/A (the “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“Reform Act”) regarding future events and the future results and prospects of NEXT-ChemX Corporation (the “Company”). In particular, these are to be found in Part I, Item 1 of this Report under the heading “Business” and Part II, Item 7 under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. Forward-looking statements set out management’s current expectations, estimates and projections in particular in relation to the Company’s future business and are based on certain assumptions about future events. Any statement contained herein that does not directly relate to any historical or current fact is a forward-looking statement within the meaning of the Reform Act. Words such as “future,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “predicts,” “will,” “would,” “could,” “can,” “may,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, those discussed in, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 and elsewhere in this Report as well as those discussed from time to time in the Company’s other Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions. Such forward-looking statements speak only as of the date of this Report or, in the case of any document incorporated by reference, the date of that document, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Report. If we update or correct one or more forward-looking statements, investors and others should not conclude that we will make additional updates or corrections with respect to other forward-looking statements. Unless otherwise stated, all information presented herein is based on the Company’s fiscal calendar, and references to particular years, quarters, months or periods refer to the Company’s fiscal years ended in December and the associated quarters, months and periods of those fiscal years. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2024 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2024 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 000-56379 | ||
| Entity Registrant Name | NEXT-CHEMX CORPORATION | ||
| Entity Central Index Key | 0001657045 | ||
| Entity Tax Identification Number | 32-0446353 | ||
| Entity Incorporation, State or Country Code | NV | ||
| Entity Address, Address Line One | 1100 South 10th Street | ||
| Entity Address, City or Town | Las Vegas | ||
| Entity Address, State or Province | NV | ||
| Entity Address, Postal Zip Code | 89104 | ||
| City Area Code | 725 | ||
| Local Phone Number | 867-0789 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | No | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 285,468 | ||
| Entity Common Stock, Shares Outstanding | 28,546,834 | ||
| Documents Incorporated by Reference | None | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Entity Common Stock, Shares Outstanding | $ 0.001 | ||
| Auditor Firm ID | 5525 | ||
| Auditor Opinion [Text Block] | We have audited the accompanying balance sheets of NEXT-ChemX Corporation (“the Company”) as of December 31, 2024 and 2023, and the related statements of operations, stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended December 31, 2024, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023 and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America. | ||
| Auditor Name | Fruci & Associates II, PLLC | ||
| Auditor Location | Spokane, Washington |